Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence, Japan, 2023

E-resources

Peer reviewed Open access

Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence, Japan, 2023

Kinoshita, Ryo; Miyamoto, Sho; Sakuraba, Shoko; Sugihara, Jun; Suzuki, Motoi; Suzuki, Tadaki; Yoneoka, Daisuke

Emerging infectious diseases 30, Issue: 6

Journal Article

We assessed SARS-CoV-2 seroprevalence in Japan during July-August 2023, with a focus on 2 key age groups, 0-15 and >80 years. We estimated overall seroprevalence of 45.3% for nucleocapsid antibodies and 95.4% for spike antibodies and found notable maternally derived spike antibodies in infants 6-11 months of age (90.0%).

Keep searching

Author

Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.

Year	Impact factor		Edition		Category		Classification
Year	JCR	SNIP	JCR	SNIP	JCR	SNIP	JCR	SNIP

Links to authors' personal bibliographies	Links to information on researchers in the SICRIS system

Source: Personal bibliographies and: SICRIS

Upload image

Shelf entry

Adding material to shelf was successful.

Adding material to shelf failed.

It was not necessary to add the material to the shelf.

Permalink

E-mail

Impact factor

Select the library membership card:

DRS, in which the journal is indexed

Citations

Theme